Lipid Target in Very High-Risk Cardiovascular Patients: Lesson from PCSK9 Monoclonal Antibodies

Lipid Target in Very High-Risk Cardiovascular Patients: Lesson from PCSK9 Monoclonal Antibodies

The role of low-density lipoproteins (LDLs) as a major risk factor for cardiovascular disease has been demonstrated by several epidemiological studies. The molecular basis for LDLs in atherosclerotic plaque formation and progression is not completely unraveled yet. Pharmacological modulation of plas...

Full description

Bibliographic Details
Main Authors: Giovanni Ciccarelli, Saverio D’Elia, Michele De Paulis, Paolo Golino, Giovanni Cimmino
Format: Article
Language:English
Published: MDPI AG 2018-03-01
Series:Diseases
Subjects:
lipoproteins
atherosclerosis
cardiovascular risk
statin
PCSK9
Online Access:http://www.mdpi.com/2079-9721/6/1/22

Similar Items

Similar Items